Try our Advanced Search for more refined results
Life Sciences - April, 2013
300 articles
- Teva, Orchid Settle Patent Dispute Over Azilect
- Teva Loses Amgen Spying Suit Over Blood Drug Secrets
- Compounding Bill May Hand FDA New Power Over Health Care
- Plan B Approved For Ages 15 And Up Without Prescription
- No Shrinkage Of $459M Fine For Male Enhancement Maker
- Bayer Workers Want Clock Stopped In $100M Sex Bias Case
- Humira Was A Factor In Widespread Infection, Doctor Testifies
- German Court Halts Sales of Boston Scientific Stents
- SportPharm Seeks Indemnity In Ex-USC Player's Pain Med Suit
- Sealing The Deal: O'Melveny Nails Historic Buy For China's BGI
- Forest Labs Says 3rd $100M Sex Bias Complaint Still Flawed
- EU Court Blocks Regulator From Releasing Drug Trial Data
- EU's New Package Of Consumer Product Safety Rules
- Eli Lilly Says It Warned Doctors Of Cymbalta 'Brain Zaps'
- Novartis Dismissed Drugs' Link To Bone Death, Doc Testifies
- After Win, FDA May Backtrack On More Device Approvals
- Merck Wins First Femur-Related Fosamax Suit
- Merck Escapes Suits Over Prescription Copay Coupons
- Qiagen Buys Genetic Data Processor In $105M Cash Deal
- FDA Rejects Pair Of Gilead HIV Drugs
- P&G Asks 11th Circ. To Bar Experts In Fixodent Case
- GSK Changes Potiga Label In Response To Eye, Skin Issues
- Schumer Pushes For Further Hydrocodone Restrictions
- Husch Blackwell Adds Product Liability Pro From Jenner
- Bard Dodges Bid To Remand Vascular Filter Defect Suit
- Sullivan & Cromwell Guides Bayer's $1.1B Conceptus Buy
- Auxilium Inks $657M Deal For Erectile Dysfunction Drug Co.
- Pharma IP Rights In China: Avoiding The Antitrust Pitfalls
- Second NJ Trial Underway In Novartis Bone Drug Litigation
- Cancer Treatment Device Maker Beats Antitrust Claims
- Patient Wins $6.5M Award In 1st Actos Bladder Cancer Trial
- CareFusion To Pay $41M To End Marketing Probe
- Advance Realty Buys Former Sanofi Research Campus In NJ
- K-V Lenders Slam Creditors' Objections Over Plan Statement
- Smith & Nephew Hip Implant Suit Booted
- Fed. Circ. Allows For Some Ambiguity In Patent Claims
- Novartis Faces Another DOJ Suit Over Alleged Kickbacks
- White House Names FTC's Shelanski To Lead Oversight Body
- AstraZeneca Didn't Deserve Seroquel Extension, DC Circ. Says
- Theravance To Split To Create Firm Focused On GSK Tie-Up
- Greenberg Fends Off DQ Bid In Drug-Discount Antitrust Suit
- FDA Flubbed Approval Of Generic Cattle Med, Judge Says
- Bill Giving FDA New Power Over Compounders Unveiled
- ITC Launches Probe Of Imported Sleep Aid Devices
- Wright Accuses Arthrex Of Medical Device Trademark Ripoff
- Sequester Will Hinder Drug, Device Reviews, FDA Head Says
- Purdue, Actavis Settle OxyContin Patent Battle
- Branded, Generic Cos.' Reglan Win Stands In Appeals Court
- Foley Adds Former K&L Health Care Pro To Boston Team
- Hemispherx Misled Investors Over Anti-Fatigue Drug, Suit Says
- Abbott's Humira Letter Needed FDA's Green Light, Jury Told
- Shire Ends Patent War With Actavis, Watson Over ADHD Drug
- NuVasive Hit With Patent Suit Over Bone Screw Device
- AstraZeneca Hit With US Subpoena Over UK Plant
- Obagi Chase Ends As Investors Approve $414M Valeant Bid
- Edwards Says Heart Valve IP Still Infringed After $74M Verdict
- Belgian Drug Co. Shores Up US Biz With Okla. Distributor Buy
- Deals Rumor Mill: Verizon, Telefonica, 3i
- It's My Expert, And I'll Call Her If I Want To
- FDA Surveillance Could Actually Help Device Makers In Court
- Baxter Units Face IP Suit Over Actifuse Bone Graft Product
- 3SBio Exec, PE Firm Put Up $380M To Sweeten Go-Private Bid
- Senate Confirms Burwell As New OMB Head
- Novartis Reveals Probe Of Plant Quality Issues
- Humira Caused Serious Fungal Infection, Jury Hears
- Pharma Cos. Get Cert. In MDL Over Generic Prograf Delays
- NY Turns To Insurers To Battle Meningitis Outbreak
- FDA Unveils Tool To Detect Counterfeit Products
- Omnicare Faces Probe Over Possible FCA Offenses, Kickbacks
- IP Firm Hit With $4M Malpractice Suit Over Patent Case
- GSK Looks To Unload Lucozade, Ribena Energy Drink Brands
- FDA Head Touts Deeper Patient Input In Drugmaking Process
- Pfizer Escapes Shareholder Suit Over Wyeth Alzheimer's Drug
- Law Firms Take A Liking To Social Media Practice Groups
- FDA Releases Draft Guidance On Improved Drug Labels
- DOJ Sues Novartis Over Alleged Myfortic Kickback Scheme
- Stryker's New Claims Over XL Settlement Meet Resistance
- Ind. Compounder Recalls Drugs Over Sterility Concerns
- FTC Clears Nordic Capital's $767M Sale Of Wheelchair Co.
- FDA's OxyContin Ruling May Spur New Battles Over Generics
- Allergan, Duke Block Lash-Growth Generics
- Caronia And Harkonen — Lessons For The Gov't
- Promega Denied Do-Over On $52M Gene-Testing Patent Verdict
- Merck's NuvaRing Win Puts Pressure On MDL Plaintiffs
- FDA Cracking Down On Compounders At Historic Pace
- Justices Let Hearing-Aid Makers' $31M Patent Judgment Stand
- Stryker Urges Rejection Of Zimmer Bid For New Patent Trial
- Walgreen Hawked Bogus Joint Health Supplements, Suit Says
- Elan Rejects Royalty's New Takeover Bid After Stock Buyback
- OIG's Alert Has Broad Implications With A Hint Of Warning
- An Update On Daubert And Class Certification
- Pfizer Sues Inventia Over Generic Bladder-Control Drug
- Sanofi Can't Duck Amphastar's FCA Suit Over Lovenox
- Shire Settles Patent Row With Sandoz Over Generic Intuniv
- High-Risk Implants Need Toughest FDA Review, Group Says
- Grand Jury To Probe Compounder Over Meningitis Outbreak
- FDA Proposes OK Of Usage Symbols On Medical Devices
- Famed Tort Litigator Stanley Chesley Retires Amid Scandal
- Red Cross Says J&J's Anti-Bleeding Patches Infringe Patents
- Ingredient Maker Escapes Liability In Drug Recall Suit
- UK Antitrust Watchdog Hits GSK With Pay-For-Delay Claims
- GNC Hit With False Ad Claims Over Triflex Joint Product
- A Guide To Effective Environmental Due Diligence
- A New Weapon In Generic Drug Companies' Arsenal
- Africa — Open For Business
- Life Tech Investor Sues To Block $13.6B Buyout
- Generic MS Drug Development Was Protected, Sandoz Says
- Diabetes Drugs Have High Rate Of Cancer Links: Report
- J&J Win Highlights FDA's Impact On Hip Implant Cases
- FDA To Survey Docs, Nurses On Drug Advertising
- BakerHostetler Lures Ex-Fulbright Atty To Head FDA Group
- UK Appeals Court Sends Singulair Arguments To EU Court
- How Elan's $1B Buyback Shakes Up Looming Hostile Bid
- Insurers Win Bid To Return Avandia, Paxil Suits To Pa. Court
- Elan Buys Back Shares From J&J As $7B Bid Hangs Overhead
- Univ. Of Ala. Study Caused Infant Deaths, Suit Claims
- Kiobel Ruling Curbs Potential ATS Liability — For Now
- 3 Ways To Leverage Internet Access During Trial
- Depomed Hits Endo With Patent Suit Over Opana ER
- Galderma Must Pay Oracea Fees To NYU During Appeal
- Takeaways From 2nd-Ever Bermuda Form Insurance Case
- 5th Circ. Quashes Generic Reglan Failure-To-Warn Suit
- Roche Urges Fed. Circ. To Revive Boniva Patents
- Fla. Senate Panel Clears Bill To Strengthen State FCA
- Cooley Nabs Ex-Epstein Becker Health Practice Head
- High Court Urged To Revive Pfizer, GSK Price-Fixing Suit
- FDA Again Rejects Allergan Migraine Drug Levadex
- Volcano Hits St. Jude With New Suit In Guide Wire IP Feud
- Pharma Cos. Say Whistleblower's FCA Case Recycles Old Suits
- Get Your Facts Fast — FOIA Requests May Be Expedited
- Dems Propose Bill To Cut $141B In Medicare Drug Costs
- J&J, Dozen Other Cos. Sued Over Fluid Delivery Patent
- Jury Sides With DePuy At 2nd Hip Implant Trial
- FDA Staff Has Concerns Over Endo Testosterone Replacement
- Amgen To Pay $25M To Escape Anemia Drug Kickback Suit
- Bayer Asks 3rd Circ. To Decertify Class In Vitamin Ads Row
- FDA Blocks OxyContin Generics, Citing Abuse Risks
- Nobel Biocare To Pay Up To $1.3M To Settle Dental Implant Suit
- GSK Backed By Fed. Circ. In Leukemia Drug Patent Suit
- Plan B Should Be Over-The-Counter, Medical Groups Say
- Thoughts On Oral Arguments In Gene Patent Case
- FDA Head Admits Missteps In Run-Up To Meningitis Outbreak
- Bayer's Yaz Patent Claims Are Invalid, Fed. Circ. Says
- K-V Creditors Say Alternative Plan Is In The Works
- Alzheimer's Institute Seeks New Trial In UPenn Patent Row
- CORRECTED: Bayer Wants Rival's Flea-Killer Ads Exterminated
- Novartis Didn't Properly Test Hypertension Drugs, Suit Says
- Actos Plaintiff Deserves $5.3M For Bladder Cancer, Jury Told
- Takeda Put Actos Profits Before Patient Safety, Jury Told
- 11th Circ. Revives FTC False Ad Claim Over Supplements
- FDA To Help Drugmakers Take To Twitter, Official Says
- Justices Cast Skeptical Eye On Human Gene Patents
- DePuy Should Pay $5M For Implant 'Catastrophe,' Jury Hears
- Mexico Clears $12B Nestle-Pfizer Deal After Divestiture
- White & Case Reps Harvest In Infusion Therapy Co. Buy
- Hedge Funds Sue Pharma Co. Over $20M Note Default
- Compounders Need FDA Oversight, Markey Says
- Attorneys Reap $17.2M In Becton Antitrust Dispute
- Wachtell Guides Thermo Fisher's $13.6B Life Tech Takeover
- High Court Won't Mull Double Avandia Damages For Insurers
- How Bowman V. Monsanto May Wreak Havoc On Biotechnology
- DC Circ. Won't Kill FTC Bid For Boehringer Deal Docs
- Groups Sweat Scope Of High Court Gene Patent Ruling
- FDA Lists Poor Conditions At Compounding Pharmacies
- EU Antitrust Chief Expects First Libor Case In 2013
- FDA's Approval Of Generic Bayer Bovine Drug Suspended
- Safety Controls Eyed As New Way To Block Generic Drugs
- Merck's Fosamax Caused Broken Femur, NJ Jury Hears
- FDA To Reassess Avandia Risk After Revisited Study
- Meningitis Plaintiffs' Litigation Team Named In NECC Case
- Wal-Mart, Rite Aid Face Suit Over Glucosamine Promises
- Shire Sues Neos To Block Adderall XR Competitor
- Steptoe Lures EU Regulatory Team In Brussels
- $967B Proposed HHS Budget Receives Little GOP Pushback
- Dorsey Lures IP, White Collar Ace To Minneapolis Office
- Elan Investors OK $1B Buyback As Royalty Pharma Looms
- Manufacturers, Be Sure To Read These Tea Leaves
- Biolitec Held In Contempt Over Merger In AngioDynamics Row
- Chinese Co. Wants $153M Award Vacated In Vitamin C MDL
- Ex-FTC Head Predicts Partial Win On Pay-For-Delay
- Defunct Pfizer Unit Ends Appeal Of $8.7M Asbestos Verdict
- Stryker Recall Gets FDA's Most Serious Classification
- Schedule Killed Pfizer IP Suit, AntiCancer Tells Fed. Circ.
- Most Hospitals Use Compounded Sterile Drugs, HHS Says
- AstraZeneca Settles Generic Seroquel XR Row With Lupin
- Bayer Vitamin Claims Not Demonstrably False, Judge Finds
- DePuy Hip Implant Patient Likely Hypersensitive, Jury Hears
- Integra Recalls Collagen Products After Manufacturing Woes
- Merck Can't Boot Witnesses From Bellwether Fosamax Trial
- Bayer Sues FDA Over Approval Of Generic Cattle Antibiotic
- Post-Merck Debate Over Research Exemption For Infringement
- Sound The Alarm: Uninjured Plaintiffs Now Have Standing
- Obama Proposes Funding Boost To Drug, Tobacco Oversight
- Pfizer Breast Cancer Drug Gets FDA's 'Breakthrough' Status
- Sanofi Can't Revive Antitrust Counterclaim In Vaccine Case
- FDA Sets Consumer Test Policies As It Mulls Widening OTCs
- Mylan Blasts Apotex Challenge To Generic Benicar Exclusivity
- Actavis Settles With Medicis Over Skin Drug Generic Plans
- Bingham McCutchen Reels In DLA Piper IP Pros For LA Office
- Deals Rumor Mill: Marlin Equity, Life Tech, Dell
- Va. Takes The Lead In Biosimilar Substitution Law
- 4 Industries Facing New Heat From The False Claims Act
- Black Eye Aside, KPMG May Sidestep Legal Melee
- Merck Ignored Fosamax Femur Injury Warnings, Jury Told
- Philips Pays $5M To Settle SEC Suit Over Polish Bribes
- House Dems Want More Info On Animal Antibiotics Use
- Texas Court Won't Revive $10M Award Against Fen-Phen Atty
- Plan B Ruling Curbs FDA's Power To Restrict Drug Access
- Investors In $132M Vitacost IPO Ask 11th Circ. To Revive Suit
- FDA Warns Pfizer Italian Unit Over Contamination
- Impax Misled Investors About Manufacturing Issues, Suit Says
- Beware Pharmacy Record-Keeping Violations
- Preemption Of Research Has No Place In Gene Patent Case
- KPMG Resigns As Herbalife Auditor Amid Trading Scandal
- Nutrisystem Defeats Class Cert. Bid In Call Recording Suit
- High Court Case Could Strike Down Human Gene Patents
- Human Egg Donors' Price-Fixing Suit Survives Dismissal Bid
- Hospitals Win Delay In Drug Discount Program Deadline
- NeurogesX Can't Shake Shareholder Suit Over Exec's Exit
- Sister Of Jailed Insider Trader Nguyen Settles SEC Suit
- Stryker Hip Implant Litigation In NJ Heads To Mediation
- NJ Judge Tailors Evidence In Novartis Bone Drug Mass Tort
- Fed. Circ. Calls Foul On Cephalon's Provigil Patent
- J&J Vaginal Mesh Plaintiff Can't Remove Suit From MDL
- Scottsdale Owes Wrinkle Treatment Injury Defense, Coapt Says
- FDA Isn't Cracking Down On Social Media Ads, Report Says
- Illumina Fires Back At Suit Over Rejected $9B Roche Bid
- Merz Pharma Drops Out Of Bidding War For Obagi Medical
- Jones Day Adds Food And Drug Pro From Hunton & Williams
- Union Fund Hits Reckitt With Suboxone Antitrust Suit
- Deals Rumor Mill: Google, Billabong, Icahn
- Warner Chilcott Sued Over Loestrin Pay-For-Delay Deals
- Allergan Botox Case Should Be Killed, Del. High Court Says
- Merck Loses Injunction Bid In Generic Diabetes Drug Suit
- Greenberg Blasts DQ Bid In Drug-Discount Antitrust Suit
- Lax Ga. False Claims Law May Threaten Medicaid Incentives
- Cordis, Wyeth Urge Fed. Circ. To Revive Stent Patents
- FDA's Light Touch With Medical Apps May Let Industry Bloom
- Promega DNA Products Infringe Caltech Patent, Judge Finds
- CORRECTED Saul Ewing Adds 2 Edwards Wildman IP Attnys In Boston
- Mako's Trade Secrets Win Sidelines Rival's Sales Staffer
- Sun Pharma Agrees Not To Sell Generics Of Sleep Aid Lunesta
- Bausch & Lomb Fires Back At Eye Doctor's Trademark Claims
- FDA Must Make Plan B Available To All Women, Judge Rules
- Security Co. Blasts Lilly Insurer's $80M Drug Theft Suit
- Mintz Hires Product Liability Pair In San Francisco
- Let's Fix The Patent-Specific Preliminary Injunction Test
- Inside The FTC's Take On Generic Access To Branded Drugs
- St. Jude Defibrillator Wires Had Fatal Defects, Suits Say
- AbbVie, Teva Accused Of Pay-For-Delay On Generic Niaspan
- Pharmacists Urge Medicare Part D Plans To Follow CMS' Lead
- Supplement Trade Group Floats Voluntary Caffeine Rules
- Fed. Circ. Wipes Out $600M Patent Judgment Against J&J
- FDA Biosimilar Meetings Offer Chance To Skip Clinical Trials
- Ferring Loses Bid To Halt Ads For Watson Fertility Drug
- Chicago Law Firm Botched Vitacost's $132M IPO, Suit Says
- ACLU Joins Prescription Drug Privacy Row With DEA
- Ex-FDA Official Says DePuy Followed Hip Implant Watch Rules
- 'All Natural' ED Products Contain Hidden Risks, FDA Warns
- Dickstein Shapiro Adds Ex-Elan IP Head In Silicon Valley
- Purdue Targets Dr. Reddy's In Growing Sleep-Aid Patent Blitz
- Celgene's $5.5M Patent Buy Ends Cancer-Therapy IP Row
- A Narrow Exception To The Mensing Preemption Defense
- No Defense Reimbursement For Insurers In Wash.
- ViroPharma Didn't Defame Fired Janitors, Appeals Court Says
- Mobile Medical Apps Invite New Breed Of Product Suits
- Justices Seek Word From Amphastar In Drug Safe Harbor Case
- 1st Circ. Rules Against Pfizer In 3 Neurontin RICO Suits
- Novartis Sues Noven To Block Generic Dementia Patch
- Valeant Bids $418M To Keep Top Spot In Obagi Bidding War
- Parker Waichman Backs Bayer Over NJ Mirena Consolidation
- Troutman Sanders Beats Conflict Of Interest Claims
- Cephalon's Provigil Patent Is Enforceable, Fed. Circ. Told
- Bayer Beats Failure-To-Warn Action In Trasylol MDL
- How Lawyers Benefit From Early Neutral Evaluation
- Precision For Medicine Pulls In $150M In PE Funding
- Shire Faces Consumer Antitrust Claims Over Adderall
- Mylan Settles With Sunovion Over Lunesta Generic Plans
- DePuy Hip Developer Says He Wouldn't Use Implant
- Suit Pins Pancreatic Cancer Deaths On Merck Diabetes Drug
- Obama Launches $100M Brain Research Initiative
- Chinese Co. Northeast Settles Vitamin C Antitrust Claims
- AmerisourceBergen Brings In $308M For Pharma-Packing Unit
- Merz Tops Valeant With $383M Bid For Obagi
- AstraZeneca's Kid Asthma Drug Patent Invalid, Judge Says
- The Next Big Thing For Medical Device Clinical Studies
- Cephalon Beats Challenge To Narcolepsy Drug Patent
- Immunomedics Agrees To $18M Settlement With Broker-Dealer
- Virginia Law Raises Red Flags For Biosimilar Industry
- Pfizer Dodges Suit Over Retirement Fund Stock Plummet
- Generic Co. Lobs Antitrust Suit To Access Brand-Name Meds
- Chamber Asks High Court To Hear Fight Over FCA Changes
- J&J Must Face Tylenol Liver Damage MDL In Pa.
- Patterson Atty Gained Secrets Through Ruse, Doc Says
- Fla. Bill Axing Sales Tax On Industrial Gear Clears Panel
- Martek Dodges Antitrust Suit Over Baby Formula Additives
- India's High Court Blocks Novartis Patent, Boosting Generics
- US To Argue In High Court Challenge Of Myriad Gene Patents
- Breaking Down The Bartlett Oral Argument
- The Supreme Court Is Paying Attention To Patent Law Again